Structural predictions for the ligand-binding region of glycoprotein hormone receptors and the nature of hormone–receptor interactions  by Jiang, Xuliang et al.
Structural predictions for the ligand-binding region of
glycoprotein hormone receptors and the nature of
hormone-receptor interactions
Xuliang Jiang', Michel Dreano 2, David R Buckler3, Shirley Cheng 3,
Arnaud Ythier2, Hao Wu1, Wayne A Hendrickson1 and Nabil El Tayar 2 ,3*
1Department of Biochemistry and Molecular Biophysics, and Howard Hughes Medical Institute, Columbia University, New York,
NY 10032, USA, 2Department of Preclinical Pharmacology, Ares Serono, CH-1202 Geneva, Switzerland and 3Ares Advanced
Technology, Randolph, Massachusetts 02368, USA
Background: Glycoprotein hormones influence the
development and function of the ovary, testis and thyroid
by binding to specific high-affinity receptors. The extra-
cellular domains of these receptors are members of the
leucine-rich repeat (LRR) protein superfamily and are
responsible for the high-affinity binding. The crystal
structure of a glycoprotein hormone, namely human
choriogonadotropin (hCG), is known, but neither
the receptor structure, mode of hormone binding, nor
mechanism for activation, have been established.
Results: Despite very low sequence similarity between
exon-demarcated LRRs in the receptors and the LRRs
of porcine ribonuclease inhibitor (RI), the secondary
structures for the two repeat sets are found to be alike.
Constraints on curvature and P-barrel geometry from the
sequence pattern for repeated ot units suggest that the
receptors contain three-dimensional structures similar to
that of RI. With the RI crystal structure as a template,
models were constructed for exons 2-8 of the receptors.
The model for this portion of the choriogonadotropin
receptor is complementary in shape and electrostatic
characteristics to the surface of hCG at an identified focus
of hormone-receptor interaction.
Conclusions: The predicted models for the structures
and mode of hormone binding of the glycoprotein
hormone receptors are to a large extent consistent with
currently available biochemical and mutational data.
Repeated sequences in P-barrel proteins are shown to
have general implications for constraints on structure.
Averaging techniques used here to recognize the struc-
tural motif in these receptors should also apply to other
proteins with repeated sequences.
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Introduction
The cell-surface receptors for glycoprotein hormones
form an homologous family, as is the case for the hor-
mones themselves. The glycoprotein hormone family
comprises lutropin (luteinizing hormone; LH), follitropin
(follicle stimulating hormone; FSH), thyrotropin (thyroid
stimulating hormone; TSH) and choriogonadotropin
(CG). Receptors for LH, FSH and TSH (LHR, FSHR
and TSHR, respectively) specifically recognize and are
activated by these corresponding hormones; in addition,
LHR also serves as the receptor for CG. The glyco-
protein-hormone receptors all stimulate adenyl cyclase
when activated, which suggests involvement of G pro-
teins. Indeed, sequences obtained from cDNA and
genomic clones for LHR [1-4], FSHR [5-7] and TSHR
[8-10] show that each is a single bipartite polypeptide
chain with a C-terminal domain characteristic of G-pro-
tein-coupled receptors, including seven transmembrane
segments complete with sizable intracellular portions from
loops and the C-terminal extension, and an N-terminal
extracellular domain that belongs to the leucine-rich
repeat (LRR) superfamily [11]. Pertinent characteristics
from these receptor sequences are listed in Table 1.
Although the structure of human choriogonadotropin
(hCG) is known in atomic detail [12,13], and by
homology much can be inferred about other family
members, the three-dimensional (3D) structures of the
glycoprotein-hormone receptors are unknown. Several
studies have, however, established structure-function
relationships, as extensively reviewed by Segaloff and
Ascoli [14], Dias [15], Combarnous [16] and Nagayama
and Rapoport [17]. Importantly, results from deletion
mutagenesis and chimeric constructions show that the
binding and activation processes are separable. There is
strong evidence that the large extracellular domains of
the glycoprotein hormone receptors are responsible for
both the receptor specificity and for high-affinity binding
[14]. In particular, high-affinity hormone binding has
been mapped to regions encoded by exons 1-8 of LHR
and FSHR [18-20]. Activation, on the other hand, has
been identified with the transmembrane domains and
this can be elicited non-specifically [19,21], presumably
though ligand-induced conformation change, as is
thought to occur in G-protein activation by other seven-
transmembrane-helix receptors [22,23].
The overall sequence homology among the glycoprotein
hormone receptors [14] suggests a common folding
topology and, by extension, a common mechanism of
binding to their hormones. The existence of the LRR
sequence motif of each receptor has led to speculation
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Table 1. Characteristics of human glycoprotein hormone receptors.*
(CG/LH)R
Number of residues
Total
Extracellular domain (ECD)t*
Transmembrane domain (TM)*
Intracellular domain (ICD)*
Cysteines in ECD
Cysteines in TM+ICD
Potential N-glycosylation sites§
Potential tyrosine phosphorylation sites
Inter-receptor identity (%;overall, ECD, TM, ICD)
hLHR
hFSHR
Chromosome location#
Receptors cloned from other species
Inter-species overall identity (%)**
Genomic sequences#
No. of Exons
Span
699
363
265
71
12
13
6
2 p21
rat, pig, mouse,
quail (fragment)
84-94
11
>75 kbp (human)
695
366
265
64
11
12
4
54, 44, 69, 38
2 p21
rat, cow, sheep, horse,
crab-eating macaque
87-97
10
>84 kbp (rat)
763
417
265
81
11
13
5
0
53,44, 71, 32
49, 38, 69, 34
14 q31
rat, mouse, cow, dog,
guinea pig (fragment)
84-93
10
>60 kbp (human)
*Data is from our inventory of non-redundant databases (PDB+SwissProt+SPupdate+PIR+GenPept+GPupdate). The sequences with
associated accession numbers for this inventory were: LHR (human, A23728; rat, A49744; pig, A41344; mouse, P30730; quail,
S75716), FSHR (human, JN0122; rat, A41729; cow, L22319; sheep, JC1493; horse, S70150; crab-eating macaque, JN0898) and
TSHR (human, A36120; rat, P21463; mouse, MMU02601; cow, BTU15570; dog, P14763; guinea pig, A49196). tThe extracellular
domain includes the signal peptide. *The boundaries of the ECD, TM and ICD were adopted from Segaloff and Ascoli [14].§These
sites within the ICD were identified using MOTIFS program of the GCG package. #This information was from references
[3,6,10,73,741. **The identity calculations were conducted using BESTFIT program of the GCG package.
that the overall fold would include a repeating substruc-
ture. There is appreciable homology among the repeats,
and for each receptor exons 2-8 correspond to individual
repeats. Although previous secondary structure predic-
tions were inconclusive [4,24,25], the recently deter-
mined crystal structure of porcine ribonuclease inhibitor
(RI) [26], a member of the LRR superfamily, demon-
strates that its repetitive LRR motif reflects repetitive ox
hairpin units. Visual inspection revealed that the inner
diameter of RI could accommodate the shorter dimen-
sions of hCG (the X-ray crystal structure of hCG has
been shown to be elongated with long and short axes
[12]), and indeed ribonuclease A binds to the inner sur-
face of the horseshoe-shaped RI with overlap onto the
rim of 3 to ot loops [27].
As specificity and high binding affinity appear, in large
measure, to associate with the LRR motif region derived
from exons 2-8 of the glycoprotein hormones, we have
undertaken to analyze the structure of this region by sec-
ondary structure prediction and 3-barrel-geometry
analysis. Our results reveal that the LRRs of the glyco-
protein hormone receptors correspond to strand-helix
repeats, as for RI, and that exon boundaries are in the
middle of 3 strands. A 3D model constructed for this
portion of LHR is complementary in shape and electro-
static characteristics to the surface of hCG when the two
components are centered at the identified focus of hor-
mone-receptor interaction [18]. This model provides a
consistent framework for understanding biochemical and
mutational data across the families. In this article, amino-
acid residue numbers for glycoprotein hormone recep-
tors correspond to the human species, starting from the
first coding methionine. Different residue numbers may
be assigned in original references which are indicated in
the following parentheses.
Results
In light of the LRR sequences in common between the
glycoprotein hormone receptors and RI, we have con-
sidered the possibility that the RI 3D structure might
provide a suitable framework for modeling the tertiary
structure of these receptors. In this analysis we have used
the gene sequences for the receptors as a guide. In these
gene structures [3,4,6,8] exons 2-8 show a remarkable
correspondence to LRRs [3]. This contrasts with the
original suggestion of fourteen LRRs by McFarland et al.
[1], on the basis of cDNA sequence for LHR. There may
indeed be an adjoining LRR in exon 1 and two addi-
tional repeats at the start of exon 9 [4], but the bulk of
exon 1 and exon 9 clearly differ from LRR sequences.
Exons 10 and 11 (combined to form a single exon 10 in
FSHR and TSHR) contain the G-coupled receptor
domain. Apart from the LRR segments, however, there
are no detectable similarities of the receptor sequences
with known 3D structures. Hence, we have focused
attention on exons 2-8 which, fortuitously, correspond
to major determinants of hormone binding.
Sequence alignment
An alignment of the amino-acid sequences for
the repeats encoded by exons 2-8 of the individual
receptors (Fig. 1) reveals a consensus sequence of XcDX s -
(IX2 (X 4FX 54)X2 ( ), where X indicates any amino acid,
(F refers to leucine or other hydrophobic residues (notably
FSHR TSHR
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Fig. 1. Sequence alignment and averaged secondary structure prediction profiles for the leucine-rich repeats of human LHR, human
FSHR, human TSHR and porcine RI. Amino-acid residues are shown as single letter codes. Consensus hydrophobic residues are
shaded. The dashes denote gaps and two letters in plain text font in a single letter space refer to insertions introduced for optimal align-
ment. Residue numbers are marked at each end of each segment; these start from the first coding methionine residue. Reliability
indexes (0-9, from 0 for the lowest to 9 for the highest confidence) are given for the likelihood of the residue at each position to be in a
helical (prH), extended/P strand (prE) or loop (prL) conformation. These values are averages from the individual reliability indices from
the secondary structure prediction program PHD. The predicted conformation (H for helix, E for extended/p strand, and L for loop), that
is, that with the highest index, is recorded as PHD. 'Crystal' is the secondary structure most commonly found at the corresponding posi-
tion in the porcine RI crystal structure (a for a helix, P for [3 strand and for loop).
isoleucine or valine) and F is for phenylalanine. The pair-
wise identity levels for the LHR alignment range from
12-36% with an average of 20.7%. When we aligned the
repeats (which included type A, type B and flanking
repeats [26]) from RI with those from the receptors, we
found that the receptor intron boundaries happen to be in
the middle of RI 3 strands. The resulting RI sequence
motif XX 4()X 7LX3LX 6LX 2 L is similar, but it has
stricter dependence on leucine (L), greater length and a
distinct pattern in the central portion of the repeated pat-
tern. Indeed, Kobe and Deisenhofer [11,26] have observed
that the most conserved residues throughout this LRR
superfamily all cluster around the 3-strand region of RI.
Secondary structure
As the LRRs in the glycoprotein hormone receptors are
shorter than those in RI and have a somewhat distinctive
motif, it was not clear whether these shorter repeats
adopt the same 3Pot conformation as in RI. Kobe and
Deisenhofer have discussed three possible LRR confor-
mations [11,26]. The first possibility is that the shorter
repeats do adopt a similar 3Po conformation, as demon-
strated by the flanking repeat in RI. The second and the
third alternatives are two kinds of 3-roll folds, as found in
pectate lyase C and alkaline protease.
In order to identify the structural motif for the shorter
repeats in the glycoprotein hormone receptors, we
applied a recently available program, PHD, to predict the
secondary structures of these receptors [28]. The PHD
algorithm uses a two-layered feed-forward neural net-
work on a non-redundant database, together with evolu-
tionary information, to predict the secondary structure of
water-soluble proteins. Depending on the number of
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Fig. 2. Secondary structure prediction
for human LHR, FSHR and TSHR and
porcine RI. (a) The full prediction from
the PHD program for the amino-acid
residues encoded by exons 2-8 of
human LHR (the full predictions for
human FSHR and TSHR are very similar
to that for human LHR). (b) The sec-
ondary structure predictions for all four
proteins after profile averaging across
different repeats. The symbols for
helices, arrows and arcs in the far right
panel represent the helices, strands
and loops as observed at corresponding
positions in the RI crystal structure.
homologs within the same evolutionary family in Swiss-
Prot database, the prediction reaches the accuracy of
72±9%. The predicted structure for the receptor extracel-
lular domains showed a repeating pattern for exons 2-8
with the highest reliability indexes in the middle region
of exons for an ot helix, near the boundary for a strand
and in between for loop conformation. The prediction
for LHR is shown in detail in Figure 2. When these three
kinds of reliability indexes are combined, the prediction
showed a clear 1-strand/a-helix alternating pattern.
In light of the periodicity in primary structure and in
secondary structure profiles, we averaged the reliability
indexes in different exons. The averaged patterns for
LHR, FSHR and TSHR are all very similar and, more-
over, there is a striking similarity between patterns from
the receptors and those from RI, which served as a con-
trol for the secondary structure prediction (Fig. 2). A
noteworthy difference between the amino-acid residues
encoded by exons 2-8 of these receptors and RI occurs
in the middle of the exons where helix probability is
somewhat diminished and loop propensity enhanced rel-
ative to RI. This is consistent with non-regular, perhaps
kinked, helical segments.
Receptor models
The secondary structure prediction of a repeated alterna-
tion of 3 and at segments clearly places the LRR por-
tions of glycoprotein hormone receptors in the a/13 class
of proteins. The regularity of these repeats also implies a
regularly repeated tertiary structure. Resemblances to RI,
both in sequence pattern and in secondary structure,
make RI an obvious model for the 3D structure of these
portions of the receptors. Despite this, detailed modeling
is not entirely straightforward, as the overall sequence
similarities are only at a random level. Thus, it is impor-
tant to consider possible variations from the RI mode of
repeated 13a structural units.
Other proteins, besides RI, that feature quasi-regular aot
repeats include triose phosphate isomerase (TIM) [29]
and ribonucleotide reductase R1 (RRR1) [30]. Like RI,
the oa segments of these proteins are also related by
circular symmetry but with much greater ring curvature:
TIM barrels close in eight repeats and the curvature in
RRR1 gives closure in ten repeats whereas 21 repeats
would be required to close the circle with RI repeats
[26]. Ring curvature in TIM barrels associates with incli-
nations of both 3 strands and at helices with respect to
the cylinder axis, whereas in the less curved RI structure
both elements run essentially parallel with the cylinder
axis. The possibility that 13-sheet twisting might lead to
helical rather than circular symmetry [11,26], giving a
lock-washer-like structure, adds another variable.
Unfortunately, there is insufficient information to specify
completely the degree of ring curvature, inclination
angles for 3 strands and a helices, and the helical twist
of the parallel 3 sheet in the LRR structures of glyco-
protein hormone receptors. Sequence and secondary
structure patterns do limit the possibilities, however.
Firstly, sequences for the 3-strand segments of the LRRs
generally have polar residues alternating with the con-
served large hydrophobic residues of the repeat pattern
(Fig. 3a). By contrast, for TIM barrels both helix-facing
and barrel-facing residues tend to be hydrophobic at the
central equatorial plane [31,32] (Fig. 3b). Thus, whereas
TIM barrels are filled with hydrophobic residues and
exclude solvent, we expect a highly charged cylinder
interior for the receptors. This implies a large radius of
curvature for these structures. Secondly, the prominently
repeated sequence pattern itself constrains the mode of
registration of strands in a parallel 3 structure. This idea
requires elaboration.
The geometry of strands in a 3 barrel can be specified by
the number of strands, N, and the McLachlan's shear
number, S, which measures the total stagger of residues
across a 3 sheet [33-35]. The repeated, lattice-like inter-
actions of a regular structure require that the shear per
strand (S/N) is an even integer. Indeed, S/N=2 for the
exactly repeated sequences in axial barrels of ovomucoid
third domains and at rhinovirus pentamer axes [35]
(Fig. 3c), and S/N=O for RI where the sequences are
quasi-repeated [11]. There is no regularly repeated
sequence pattern for TIM barrel structures because, with
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Fig. 3. Representative -barrel structures
shown as unrolled sheets: (a) ribonucle-
ase inhibitor, RI; (b) triose phosphate
isomerase, TIM; and (c) the human rhi-
novirus (HRV) pentamer from the icosa-
hedral fivefold axes. In each case, the
barrel axis is vertical and the view is
from inside of the barrel. Residues are
identified by the single letter code on
open circles for side chains that point
into the barrel interior and by filled cir-
cles for those that point away (toward
the c helices in the case of RI and TIM).
RI, TIM and HRV are examples of cases
with shear per strand, S/N, of 0, 1 and 2
and strand inclinations of 0, 36 ° and
55 ° , respectively.
(a) 456 430 401
Res. No. 454 426 397
(b)
373 344 316 287 259 230 202 173 145 116 88 59 31 6
369 9 141 112 84 55 27 2
369 340 312 283 255 226 198 169 141 112 84 55 27 2
231 209 164 126 93 64 43 11
TIMR 10 0 
Res. No. 227 205 160 122 89 60 39 7
(c)
S/N=1, the strand residues pack into distinctive environ-
ments on neighboring strands and helices. When consid-
ering the LRR structures of the glycoprotein hormone
receptors, the 13-strand inclination angles required for
S/N>4 would be unprecedented, and that for S/N=2
(approximately 550) would seem to imply relatively long
repeat lengths whereas these receptor repeats are shorter
than either TIM barrels or RI repeats. It seems most likely,
then, that S/N=0. In the case that the helices are also
non-inclined, as seems likely for the shortened segments
in these receptors, the curvature must also remain essen-
tially the same as in RI, from characteristic helix-helix
and helix-sheet packing dimensions. Other solutions, such
as the formation of a helically twisted but registrated sheet,
cannot be excluded; however, the non-inclined structure
of RI is one of the few possibilities compatible with the
strict sequence pattern of LRR proteins.
Given the likelihood of non-inclined strands and a large
radius of curvature, we took the RI structure as a plausi-
ble hypothesis to test as the basis for a 3D model of the
repeat segment of the glycoprotein hormone receptors.
This, of course, requires an alignment of sequences.
Unfortunately, by comparison of the LHR sequence
with several clearly unrelated sequences, the similarity
between RI and LHR was found to be no higher than
random. Hence, this cannot be considered a case of
homology modeling; instead it is an instance of model-
ing by pattern matching. We have therefore aligned
the hormone and RI repeat profiles emphasizing the
correspondence of secondary structural patterns.
The profile alignment (Fig. 4) was constructed to facilitate
the modeling rather than to maximize sequence identities.
7 7 7 7 7
HRV No. 2 2 2 2 2
Res. No. 2 2 2 2 2
Fig. 4. Alignment of the repeat sequences for the LRRs of human
LHR, FSHR and TSHR with those of porcine RI. The averaged
secondary structure predictions from Figure 1 are given for each
receptor sequence and observed conformations are given for RI.
This alignment was used in the construction of the receptor mod-
els. Consensus hydrophobic residues are shaded. Dashes refer to
gaps. Position numbers are marked below the alignment.
It was made to optimize the matches of hydrophobic core
residues, to place gaps in the connecting loop segments,
and to reflect distortions predicted by the PHD program
for the middles of helices. There is redundancy in the
possible frame of origin in superposition, but we found
little difference in similarity with origin shifts. A satis-
factory choice was obtained by aligning the LRR of exon
2 from the receptors with the second repeat from RI.
Although the profile alignment (Fig. 4) enforces pattern
similarity, the actual identity level is very low. The result-
ing match between exons 2-8 of LHR (51-232) and RI
(25-232), which includes 22 gaps imposed by our profile
alignment, has only 11.6% identity and 37.1% similarity.
The corresponding matches between RI and FSHR or
TSHR have similar levels of agreement.
In light of the low level of sequence identity and uncer-
tainty about the nature of distortions in the helix seg-
ments, we have been conservative in the model building.
The RI framework of strands and helices was held fixed,
1346 Structure 1995, Vol 3 No 12
Fig. 5. Schematic representations of the
models for the leucine-rich repeat portion
of the extracellular domain of the recep-
tors for glycoprotein hormones. (a) View
of the human LHR model along the barrel
axis, from above into the strands. (b)
View of the LHR model from inside the
barrel, rotated 90° about the horizontal
from (a). The strands are shown as
arrows, helices as cylinders and loops as
threads. For ease of representation, the
two discontinuous helical regions in each
repeat, as predicted from the PHD pro-
gram, are shown as one continuous helix.
The disulfide bridge between strands 4/5
and 5/6 is in yellow, and potential N-gly-
cosylated asparagine residues are in blue.
CP3 atoms for residues from the 13 sheet
that point into the barrel interior are
shown in green. The unmodeled N- and
C-terminal portions of the extracellular
domain are represented by ellipsoids. (c)
Unrolled sheet from the LHR model.
(d) sheet from the FSHR model. (e)
13 sheet from the TSHR model. In (c), (d)
and (e) side-chain orientations are indi-
cated as in Figure 3. The arrows refer to
the exon boundaries. (a) and (b), were
generated with SETOR [75].
and gaps were adjusted by substituting fragments from a
structural database. Intentionally, we did not subject the
models to energy minimization as the limited sequence
similarity precludes such detail in these models. The
model obtained for LHR is shown in Figure 5a,b. The
LRR region forms a semi-barrel, half the span of RI and
just over a third of a complete circle. N- and C-terminal
extensions, for which we have no basis for 3D conjec-
ture, must somehow embed this unit. We believe that the
,3 strands in the 3D models are more reliable than other
parts because the reliability indices were high for residues
in the -strand region, the hydrophobic residues were
well aligned and almost no gaps were introduced in the
alignment. Sequence patterns for the 13 sheets of all three
receptor models are shown in Figure 5c-e. In terms of
biological function, for reasons discussed below, it is the
reliability of the receptor model in the ,8-strand region
that is of greatest concern as this is the region likely to be
involved in hormone-receptor interaction.
Model of the hCG-LHR complex
Assuming our structural predictions for the LRR repeat
regions of the receptors, which include the major hor-
mone-binding determinants, are correct, we have
attempted to model the hormone-receptor complexes.
As the hormones have x chains in common and quite
homologous chains, a plausible universal complex
model could be constructed; however, we were aware of
many uncertainties, as the heterodimer interface and the
conformation of FSH and TSH might not be identical to
those of hCG. Moreover, some conformational change
in the hormone is possible, perhaps even likely, on com-
plex formation. The resulting receptor models are also
necessarily rather crude. Furthermore, modes of binding
do not seem to be identical from LH/CG and FSH [19]
to TSH [16]. On the basis of these considerations, and
the fact that hCG is the only glycoprotein hormone
whose crystal structure is available, we focused on a
model for the hCG-LHR complex so as to keep the
degree of the uncertainties to a minimum. Nevertheless,
evolutionary economy and cross-activating chimeras
[19-20] suggest that an understanding of any one
complex should be instructive for the whole family.
The constraints available for consideration in possible
models for the binding interaction between hCG and
LHR include mutational and biochemical evidence, elec-
trostatics and shape. There is a substantial body of evidence
from mutational studies on hCG that can be used to iden-
tify sites involved in receptor binding [18,36-38], and the
electrostatic potential at the surface of hCG that encom-
passes these sites is highly positive [12]. A comprehensive
analysis of LHR point mutations has not been reported in
detail, but studies on the binding of hCG and hFSH to
LHR/FSHR chimeras find that only residues 115-192
(93-170) from LHR are required for selective binding of
hCG [18,19]. From correlations of inter-species binding
specificities to primary sequence of the 13 subunit [39], and
from a set of hCG/FSH chimera studies [18], it has been
shown that residues 94-99 are responsible for selective
hCG binding (whereas residues 101-109 are important for
selective binding in FSH). We have made the simplifying
assumption that this region on hCG is associated with the
115-192 segment (predominantly exons 5 and 6) of LHR.
Electrostatics and shape further restrict the mode of
interaction. Given the predominantly positive binding
surface of hCG (Fig. 6a,b), one expects a complementary
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Fig. 6. Electrostatic potential on the sol-
vent-accessible surface of hCG and LHR.
(a) Front view of hCG showing the bind-
ing surface. (b) Back view of hCG. (c)
Front view of LHR showing the inner sur-
face. (d) Back view of LHR showing the
outer surface. The front and back views
of each are related by 180 ° rotation
along a vertical axis. Negative potential
is colored red and positive potential,
blue, with greatest saturations at + 10 kT,
respectively. (The figure was generated
using the program GRASP [72].)
negative surface on the receptor. It is clear from the elec-
trostatic surface of the receptor model (Fig. 6c,d) that
such a negative feature exists on the inner surface of the
LRR barrel, but not on the helical side. Then, if hCG is
to bind to the inner surface, the complementarity in
shape dictates that the long axis of hCG must be roughly
along the barrel axis. The position of the determinant
loop in hCG is such that the hormone must extend from
both ends of the barrel. In this respect the proposed
complex differs from that of ribonuclease A with RI,
where binding is also in the barrel interior but with the
ligand only extending beyond one end [27].
Shape and electrostatic complementarity can be main-
tained in either of two orientations of hCG along the
barrel axis. In one, if we view the receptor as in Fig-
ure 6b (i.e. looking into the barrel interior with 3 strands
running upward from N to C), loops L13 and L313 of
hCG will be up at the top (Fig. 7a); in the alternative,
keeping the hormone fixed, the receptor must be ori-
ented with strands running downward (Fig. 7b). At
present we have no strong basis for choosing between
these, and the orientation taken for the more detailed
model (Fig. 7c,d) is arbitrary. There is insufficient infor-
mation to define the complex structure with precision,
but the orientation and position need to be within
approximately 250 and 5 A, respectively, of the illustrated
complex (or its counterpart orientation) in order to meet
the assumptions used in this modeling.
Discussion
As we have emphasized in the preceding sections, our
predicted models for the receptors and for the mode of
hormone binding are relatively crude. One cannot
expect, and we have not attempted, to achieve stereo-
chemical detail in side-chain interactions when sequence
similarity with the template structure is at such a low
level. On the other hand, this structural hypothesis is
quite explicit with respect to hormone-binding epitopes.
Segments of the receptor that are in helical portions of
the model are specifically predicted not to be in direct
contact with the ligands, and much of the inner surface
of the 3 barrel, along with portions of contiguous loops,
are predicted to be at the binding interface. Moreover,
the model is specific about the disposition of exposed
residues at the binding surface (Fig. 5c-e). Although
we have specifically constructed the model for an
hCG-LHR complex, we expect that the mode of bind-
ing of other hormones to their receptors will be similar
as the components are homologous and receptor
chimeras mixing transmembrane and extracellular por-
tions respond fully to the hormone cognate with the
extracellular portion [19,20].
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Fig. 7. Schematic representation of the
alternative models for the complex
between hCG and human LHR. (a)
Front view, as in Figures 5b and 6c, for
one alternative; (b) front view of the
alternative model; (c) side view of
model in (a); (d) view of model in (a)
along the barrel axis of the receptor
model. The a subunit of hCG is shown
in red, the p subunit is in blue, and the
receptor is in yellow. In parts (a) and (b)
ellipsoids are drawn to represent the
unmodeled N- and C-terminal portions,
and the direction of a strands is indi-
cated by arrows. In (c) and (d), N-linked
glycosylation sites on hCG are marked
with blue spheres except for Asn52a,
for which the first sugar residue is
shown in green as a space filling model,
and the portions from exons 1 and 9-11
of the receptor were not included. On
the basis of biochemical and mutational
evidence, it is the lower portion in the
side views, including loops Llla, L3a
and L2. and the extended a chain
C terminus, that would contact the
transmembrane portion of the receptor.
(Parts (a) and (b) were generated with
GRASP[72] and parts (c) and (d) were
generated using SETOR [75].)
There have been a vast number of biochemical and
mutation studies related to the interactions of glyco-
protein hormones with their receptors. We were aware of
many of these when we built the models; but, feeling
that these results would not suffice as a definitive picture
of the complex structure, we only based our modeling
on a minimal, but particularly incisive, subset of the
observations. Our result then takes the form of a hypoth-
esis to be tested against extant data and, if still valid,
against prospective experiments. Relatively few existing
data provide a direct test of the receptor model, but
tests of the proposed complex necessarily also test the
predicted receptor structure. Here, we first examine
the models against available data and then consider
implications for receptor-mediated G-protein activation.
Cystine bridge
Unlike the situation for RI, which is a cytoplasmic pro-
tein with cysteine residues throughout the structure, the
cysteine residues in extracellular domains of the receptors
are likely to be disulfide-bonded. Disulfide pairings have
not been described for any of the receptors, but one
expects that all cysteine residues will either be in cystine
bridges or have buried thiol groups. For the most part,
the receptors have their extracellular cysteine residues
clustered in exons 1 and 10-11, outside the LRR seg-
ments. Only LHR, with two cysteines, has any at all
within exons 2-8. These are at positions (106 and 131)
that are juxtaposed on the face of neighboring 13 strands
in the LHR model (Fig. 5a-c) and poised to form an
intra-sheet disulfide bridge as found in the D2 domain of
CD4 [40]. Such a cystine bridge could not form if the
strands were inclined, which is a confirmation of our
assumption that S/N=0.
Location of carbohydrates
The carbohydrate moieties of the gonadotropin receptors
have been shown, by site-directed mutagenesis [41] and
deglycosylation [42,43], not to be involved in the recog-
nition and high-affinity binding of the LH/CG receptor.
The orientation of the carbohydrate side chains on the
receptor-hormone complex was also studied by the com-
bination of cross-linking and glycosidase digestion meth-
ods [44]. These results suggest that the oligosaccharide
side chains of the receptor are directed away from the
hormone-binding region. In the present study, the 3D
model of LHR shows that the potential N-glycosylation
sites Asn99, Asn174 and Asn195 (Fig. 5) are located at the
outer surface (i.e. as components of helices or loops).
Glycosylation at these residues is, therefore, not expected
to interfere with hormone binding at the 3-strand inner
surface. For FSHR, Asnl81 is located at the outer sur-
face, whereas Asn189 is located at the inner surface where
glycosylation would be expected to hinder hormone
binding. In keeping with predictions from the model,
Davis et al. [45] have recently shown that an N-linked
carbohydrate is found, in the extracellular domain of
hFSHR, at Asn181 (174) but not at Asn189 (182).
Biochemical experiments on complex formation
There is support for the model from peptide competition
experiments. Only one synthetic peptide from the LRR
region in a comprehensive overlapping series taken from
rat LHR was active in competing for hCG binding [46].
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A short active subfragment, residues 124-137 (102-115),
has strand 4/5 (Fig. 5c) at its center. As these experi-
ments were conducted under oxidizing conditions, this
peptide may well have formed a disulfide-bridged dimer
(mimicking the pair of strands 4/5 and 5/6) to enable
it to bind at the 40 micromolar level, as observed.
Antibody binding to hCG in the presence and absence of
the receptor also supports our model. In particular, it is
in keeping with the model that loop L33 of hCG is
accessible for antibody binding in the complex [47] and
parts of the Llao and L3a loops are also recognized by an
antibody when hCG is bound to a truncated receptor
lacking exon 11 [48].
Mutagenesis of the receptors
On the basis of our model, mutations located at receptor
inner surfaces could be expected to affect the affinity of
hormone binding, and those on the back side should not.
To be discriminating, the mutated segments must be
rather small, unlike those in most chimeric constructs
used to define binding regions [18-20]. In this regard,
experiments on TSHR are useful. Nagayama et al. [49]
showed no significant effect on the binding of either
hCG or hTSH to rat(r)LHR/hTSHR chimeras in which
segments from exon 9 or -region segments from exons
7 and 8 were swapped, but there was a dramatic change
when a segment corresponding to -strand 7/8 was
swapped. Similarly, mutations in rTSHR (reported by
Kosugi et al. [50]) that correspond to -strand 1/2 abol-
ished TSH binding, whereas ones corresponding to the
a region of exon 2 had no effect. The mutation
Thr62-Ala, Thr62 being the second residue after strand
1/2, also affected TSH binding.
Studies of point mutations on the glycoprotein hormone
receptors also shed light on the binding mode of the hor-
mones to their receptors. Huang and Puett [51] exam-
ined the functional consequences of point mutations in
the extracellular domain of rLHR. These mutations
involve residues with ionizable side chains that are con-
served in the three glycoprotein hormone receptors
LHR, FSHR and TSHR. It was found that mutation of
residues Glu154 (132) and Asp157 (135) (D Puett, per-
sonal communication) led to undetectable binding
whereas the mutations of Lys77 (55), Glu87 (65), Glu90
(68), Argl36 (114) and Lys143 (121) had no effect on
either hCG binding or signal transduction [51]. Glu154
and Asp157 are located in the 3 sheet or in immediately
adjacent positions, and hence their involvement in the
hCG-LHR interaction is as expected. In contrast,
Glu87, Glu90, Arg136 and Lys143 are on the outer sur-
face where they would not be expected to affect
hCG-LHR complex formation, at least not directly.
Lys77 is the only exception as it is located in the 3 sheet
in our model and its single replacement with an oppo-
sitely charged amino-acid residue had no significant
effect on ligand binding. Recently, natural variants of
hFSHR and hTSHR with defective biological activity
have been reported [52,53]. The Ala189---Val mutant ip
hFSHR was shown to have normal ligand binding in
keeping with its a-helical location in the model. Unfor-
tunately, binding assays were not performed for the
Pro162---Ala (loop) and Ile167--Asn (helix) mutations
in hTSHR. The basis for reduced signal transduction in
these natural variants remains unclear.
Mutagenesis of the hormones
There have been extensive mutational studies on hCG
which, taken together, implicate a rather contiguous por-
tion of the hCG surface in receptor binding. These
include exposed residues Arg94, Arg95, Ser96, Asp99,
Lysl04 and Lys2 of the subunit [36,37,54] and Phe33,
Arg35, Tyr88 and Tyr89 of the a subunit [55-57]. Only
Lys2 from among these is not in the vicinity of the
receptor in our model for the current portion of the
complex. From the studies on hCG/hFSH chimeras [18],
it is clear that hFSH residues in the span 101-109 of the[ subunit are important for FSH binding. The segments
from the 3 subunit correspond to the embracing seatbelt
[13] which, together with adjacent a-subunit elements,
forms a waist-like surface that is matched in the model by
the semi-circular inner surface of the entire barrel.
This, in turn, is compatible with TSHR mutations that
implicate both end strands, 1/2 [49] and 8/9 [50], in the
binding interaction.
Transmembrane activation
G-protein-coupled receptors comprise the largest group
of transmembrane receptors. Ligands vary from small cat-
echolamines to peptides to large proteins like glyco-
protein hormones [22]. Although extracellular domains
are essentially non-existent for many of these receptors,
others besides the glycoprotein hormone receptor do
have substantial domains outside the defining seven-trans-
membrane-helix portion. Elegant studies on rhodopsin
and -adrenergic receptors have placed their binding site
between helices within the transmembrane domain and
suggest that conformational changes elicited by the bind-
ing are responsible for signal transduction [23,58]. Situa-
tions in other systems are less well established, but
it seems likely that all G-protein-coupled receptors will
feature ligand-induced conformational change.
Two alternative scenarios have been considered for trans-
membrane activation of the glycoprotein hormones: an
indirect activation mode that involves conformational
changes of the extracellular domain of the receptor
[9,19] and a direct activation mode that places some parts
of the hormone directly in contact with the trans-
membrane domain [9,19,25]. Our model for the com-
plex was constructed as a rigid-body fitting of the two
components. When considered in the light of available
evidence, this model suggests that a direct interaction of
the hormone with the transmembrane domain of the
receptor could suffice.
Several experiments suggest that glycoprotein hormone
receptor binding and receptor activation are decoupled.
Firstly, although high-affinity binding to the hormone
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maps to the extracellular domain of the receptor, Ji et al.
[21] detected low-affinity binding (Kd=10-6 M) and acti-
vation by hCG with an LHR construct truncated to
delete essentially the entire extracellular domain. More-
over, as noted above, extracellular/transmembrane
chimeras cross activate with the specificity of the extra-
cellular portion [19]. Secondly, on the part of the hor-
mone, modifications at residues Lys91 of the a chain and
at the L21 loop (Keutmann loop), which are juxtaposed
in the hCG structure, have been shown to affect receptor
activation but not binding. This same effect was seen
both with the Lys9l1(oa)-Asp mutant variant of hCG
[59] and also with hCG molecules that are naturally
nicked in a selected position of the L21 loop [60]. Inter-
estingly, a complementing mutation on the first extra-
cellular loop of the transmembrane portion of the LHR
receptor (Asp397--Lys) was found that partially restored
receptor activation by the Lys91->Asp mutant of hCG
[59]. This result indicates a direct interaction between
hCG and the transmembrane domain of its receptor.
Although disorder in the hCG crystal structure precludes
Lys91(ax) from being in the complex model, the last
ordered residue Tyr89 is contacting the receptor only at
its lower periphery. Lys9l(a) can be expected, from the
model of this complex, to be exposed and available
for interaction with the transmembrane portion of the
receptor; loop L213 is exposed at the bottom of this model.
Whether or not some part of the hormone projects into
a space between transmembrane helices is not known.
Our model does, however, give some suggestions as to
the possibilities. Loops L23, Lla and L3a are all on the
bottom side of the model of the complex, along with the
C terminus of the oa subunit. They are certainly candi-
dates for making contact with the transmembrane por-
tion. Loop L23 is unusual in its folding characteristics in
that Arg43 is partly buried by hydrogen bonding with
carbonyl oxygen atoms of the neighboring chain, expos-
ing fairly hydrophobic residues [12]. Disruption of this
local conformation may account for the attenuated
receptor activation caused by nicks in this loop [60].
Hydrophobic groups in loops Lla and L3a are also
exposed [12]. In keeping with the proposed association
of this side of the complex with the transmembrane por-
tion, Llao and 3a are masked from antibodies in the
complex between hCG and the intact receptor but
become exposed when the receptor is truncated in the
complex to only the extracellular domain [48].
The role of glycosylation in activation of these receptors
is somewhat perplexing. Although deglycosylated hCG
binds to the receptor with high affinity, its activation of
cAMP production is gradually attenuated on removal of
sugar moieties [61], with greatest sensitivity to glycosyla-
tion at Asn52(a) [62]. In our model of the complex, this
residue is at the opposite end to other sites implicated in
transmembrane activation. It may be that a carbohydrate
structure at Asn52(a) somehow helps to position hCG in
a favorable orientation for signal transduction. The ability
of an antibody to restore activation by binding to the
complex of LHR with deglycosylated hCG [63,64] sup-
ports this idea. Conformational changes induced in
extracellular domains other than the LRR binding
region might also be involved. Conceivably, a lectin
homology site identified in exon 9 [1,3], but shown to be
unimportant for binding [14], may nevertheless be
important in signal transduction.
In conclusion, although there are observations that are
not easily explained by the proposed models, to a great
extent the large body of existing data is compatible with
the model. It therefore provides an appropriate hypo-
thesis to be tested in more incisive experiments.
Biological implications
Glycoprotein hormones play controlling roles in
reproduction, sexual development and thyroid
function. The focus of action of these hormones is
in the complexes they form with their respective
receptors. Therefore, a detailed knowledge about
the structures of these complexes is needed
for a molecular understanding of the biological
processes and for the design of therapeutic inter-
ventions. The model that we have developed for a
ligand-binding portion of the choriogonadotropin
receptor, and for the nature of its interaction with
the hormone, provides significant insights in the
absence of the desired crystal structure. On the
whole, the model is compatible with a large body
of experimental results relating to hormone-recep-
tor interactions and is therefore an appropriate
basis for further testing.
The model already provides a framework for
understanding some ingredients of transmembrane
activation. The extracellular, leucine-rich repeat
(LRR) portion of the receptor seems to serve as an
amplifier, enhancing sensitivity to the hormone
from a 10 M level (without the extracellular
domain) to a 10-10 M level (with the extracellular
domain) [14]. High-affinity binding of human
choriogonadotropin (hCG) to the LRR motif
region, perhaps together with changes in the rela-
tive disposition of other extracellular portions due
to carbohydrate interactions, may then optimally
orient the appropriate parts of hCG for interaction
with the seven-transmembrane-helix domain of
the receptor. This in turn is expected to lead to a
conformational change that is sensed by the appro-
priate G-protein complex, leading to stimulation
of cAMP synthesis and testosterone production.
A number of other proteins besides the glyco-
protein hormone receptors and the ribonuclease
inhibitor (RI) feature LRR repeats. Those of
known function are involved in a variety of bio-
logical processes such as embryonic development,
cell morphogenesis, cell and axon migration and
blood coagulation [11]. The techniques developed
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here can be adapted to the modeling of such
structures. When averaged secondary structure
profiles are compatible with a e-repeat structure,
our analysis of -sheet geometry suggests that the
RI template should be appropriate for such mod-
eling, even when the sequence similarity is very
low. Resulting models may prove useful for under-
standing interactions that involve the well-defined
[-sheet region of such structures.
The LRRs in the glycoprotein hormone receptors
bear a precise association with exons. Moreover,
all of the introns interrupt codons in the same
phase, which suggests that these exons may have
been generated by the exon-shuffling mechanism
described by Patthy [65]. By contrast, except for a
receptor gene from sea anemone [66], other LRR
proteins of known gene structure are either not
interrupted [67] or have introns spread through-
out the repeats such that inconsistent phases and
exon sizes result [68]. The distinctive character
of repeat patterns in RI as compared with the
receptors suggests that the two systems evolved
through separate gene multiplication events, quite
possibly from unrelated origins. This is consistent
with the low level of sequence similarity found in
our comparisons.
Materials and methods
Amino-acid sequences and atomic coordinates
Amino-acid sequences were obtained from release 42.0 of the
PIR-Protein protein sequence databank. Sequences with asso-
ciated accession numbers were used for human CG/FSH/TSH
et (Tthuap), human CG (Kthub), human FSH 13 (Fthub),
human TSH 3 (Tthub), human LHR (A23728), human FSHR
(JN0122), human TSHR (A36120) and porcine RI (A31857).
The atomic coordinate sets for porcine RI (PDB entry BNH)
and hCG (PDB entry 1HCN) were used in this study.
Sequence alignment of leucine-rich repeats
Sequence alignment of the different repeats of RI and the gly-
coprotein hormone receptors was performed manually. The
alignment for porcine RI was based on the amino-acid residues
aligned in the 3D RI structure, including type A, type B and
flanking repeats of RI. The core conserved region of 13 strands
was placed at the repeat boundary so that the secondary struc-
ture elements in the repeats of RI would be aligned in com-
mon with those predicted for the repeats of glycoprotein
hormone receptors. The alignment for the glycoprotein hor-
mone receptors was done so as to maximize the number of
identical and conserved residues at each position with required
gaps placed at consistent positions within the repeat. An auto-
mated alignment procedure [69] gave a very similar alignment,
but with inferior results in terms of above criteria.
Secondary structure prediction
The secondary structure prediction was automatically obtained
by sending the amino-acid sequences of the glycoprotein hor-
mone receptors and porcine RI to the internet address Predict-
Protein(Embl-Heidelberg.de. The version of the PHD
program used for results reported here was 5.94 317. The RI
crystal structure was not included in the database of the
program. Earlier versions were also tested and the results varied
very little. Average reliability indexes were completed for each
of the three types of the secondary structures (helix, extended
and loop), including all of the amino-acid residues shown in
Figure 1, for the respective proteins. The averaged index was
defined as the sum of the reliability indexes of all of the amino-
acid residues in the aligned column divided by the total num-
ber of the amino-acid residues in the column. The inserted
residues were counted, but gaps were excluded. Averaged pat-
terns changed very little from that in Figure 1 with different
repeat alignments by various automatic alignment procedures.
Twelve homologous sequences were used in the prediction for
the glycoprotein hormone receptors and three for porcine RI.
The reliability of PHD secondary structure predictions for this
application was tested against the known structure of porcine
RI [26]. The program predicted that the accuracy was about
72% for the glycoprotein hormone receptors and some per-
centage points lower for porcine RI. The actual accuracy of
the prediction for porcine RI was 62% (286 out of 465 residues
were correctly predicted) on comparison of the structure with
the specific secondary structure in the RI PDB file. The accu-
racy of the RI prediction after averaging was 74% (345 out of
465 residues were correctly predicted).
Alignment of receptor sequences with the RI template
The repeat pattern for the receptor sequences (Fig. la-c) was
aligned manually with that from RI (Fig. d) so as to super-
impose secondary structural elements and in a manner such
as to facilitate atomic modeling. In particular, presumed
hydrophobic core residues were aligned at positions 2, 19, 26
and 29 in the aligned repeat sequence (see Fig. 4). Two gaps
were placed in the first loop region at positions 5 and 9 so that
Cot positions from RI could be used as guides in the replace-
ment with shorter segments for loop remodeling. For receptor
repeats with three gaps in this loop region, the third gap was
fixed at position 6. The gap within the distorted helical region
was placed at position 13 so that hydrophobic residues at this
position in the type B (29 residue) RI repeats would align with
a consensus hydrophobic position in the receptors. The gap in
the second loop region was placed at the same position as the
gap in type A (28 residue) RI repeats relative to the type B
repeats. Sequence identity percentages counted gaps as single
residues for the denominator. The similarity level was calcu-
lated by the criteria used in the BESTFIT program of the GCG
package. As a control, the RI and LHR sequences of interest
were also aligned by BESTFIT. This gave 18.3% identity and
43.3% similarity with 6 gaps, which is not different from ran-
dom. Sequences from a selection of 25 proteins clearly unre-
lated to RI when aligned by BESTFIT to this same segment
from RI gave average agreement levels of 19.7% identity and
44.8% similarity with standard deviations of 3.4% in each case.
Modeling of receptors
The models of the glycoprotein hormone receptors were con-
structed on the basis of the secondary structure prediction and
RI crystal structure. Receptor sequences were aligned as indi-
cated in Figure 4, with the frame of origin set with LRR of
exon 2 in the receptors aligned to the second repeat in RI.
Thus, the segment of eight strands and seven helices contained
in residues 25-232 of RI were taken as the template for
residues 51-232 of LHR, 49-228 of FSHR and 54-236 of
TSHR. The main-chain backbone of RI was kept fixed except
for gap replacement. Fragments from the structural database in
program 'O' [70] were taken to replace loop segments. New
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main-chain positions were spliced into fixed termini with the
previous intervening positions used as guides for the Legoloop
command of O. The substitution of side chains for residues
that differ from those of RI was done with the Lego-autoSC
command of O. These operations have left several unresolved
atomic clashes, but energy minimization was deemed to be
unwarranted in view of the very low sequence similarity
between the receptors and the RI template.
Electrostatic potential calculation
The electrostatic potential at the surface of the receptors and
the hormones was calculated by the Poisson-Bolzman proce-
dure [71] and displayed with the GRASP program [72]. The
displaying range of the electrostatic potential was from -10 kT
to +10 kT. In order to reduce the effects of false detail from
inaccuracies in the receptor models, potentials were displayed
at the solvent-accessible surface (probe radius of 1.4 A) rather
than at the molecular surface.
Modeling of hCG-LHR complex
The atomic model from the crystal structure of hCG [12] was
docked into the inner space of the LHR model generated in
this study by visual optimization to the criteria of complemen-
tarity of shape, electrostatic potential, and binding determi-
nants, as discussed in the text. These fittings were conducted
with the GEMM program (kindly provided by Dr BK Lee,
National Institute of Health) for molecular manipulation and
modeling. Both models were preserved as rigid bodies. These
models, and those of the isolated receptors are being deposited
in the Protein Data Bank.
Note added in proof
After completion of this manuscript, two publications have
appeared reporting models for the extracellular domain of gly-
coprotein hormone receptors [76,77]. The TSHR model of
Kajava et al. [76] is quite similar to ours (rms deviation of 3.7 A
at Cot positions). On the other hand, the LHR model of
Moyle et al. [77] has a different alignment of sequences and
proposes a radically different mode of hormone binding.
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